Lido Advisors Reduces $3M in Cardinal Health, Inc. ($CAH)
Lido Advisors cut its Cardinal Health position by nearly 25%, holding 43,149 shares.
Key Points
- Lido Advisors trimmed its stake in Cardinal Health by 14,370 shares, now holding 43,149 shares valued at $9.54 million.
- Cardinal Health has a market cap of $52.43 billion and trades around $221.16, with a P/E ratio of 34.18.
- Insider trades include Patricia Hemingway Hall buying shares and multiple executives selling shares recently.
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
Lido Advisors has significantly reduced its position in Cardinal Health, Inc. (NYSE:CAH), according to a recent filing. The firm cut its holdings by 14,370 shares, a decrease of nearly 25%, leaving it with 43,149 shares valued at approximately $9.54 million as of the end of the reporting period.
What Changed in Lido Advisors' Cardinal Health Position
Lido Advisors' latest 13F filing reveals a substantial reduction in its stake in Cardinal Health. The firm slashed its holdings by 14,370 shares, moving from 57,519 shares to 43,149 shares. This represents a 24.98% decrease, with the remaining shares valued at about $9.54 million.
Other Institutional Activity in Cardinal Health
Institutional activity around Cardinal Health has shown varied strategies. BlackRock, Inc. slightly reduced its position by 146,765 shares, ending with 28,494,855 shares worth about $6.02 billion. In contrast, Vanguard Capital Management LLC and Vanguard Portfolio Management LLC both significantly increased their positions, adding 15,288,709 and 13,732,309 shares respectively, with holdings valued at $3.23 billion and $2.90 billion. State Street Corp cut its stake by 434,712 shares, while Geode Capital Management, LLC added 51,519 shares, bringing its total to 6,580,532 shares valued at $1.39 billion.
Cardinal Health, Inc. Stock Down 5.7%
Shares of Cardinal Health (NYSE:CAH) are trading around $221.16. The company boasts a market cap of approximately $52.43 billion and a P/E ratio of 34.18. Its forward P/E stands at 18.66, indicating expectations of future growth. Cardinal Health's stock has ranged from a 52-week low of $137.75 to a high of $233.60, with moving averages of $202.54 (50-day) and $195.37 (200-day). The company has a beta of 0.526, suggesting lower volatility compared to the market.
$CAH stock price
Daily closing prices, year to date. Not investment advice.
Recent Earnings
In its latest earnings report, Cardinal Health posted revenue of $250.74 billion, reflecting a growth rate of 11%. The company's earnings per share (EPS) stood at $6.55, with a net margin of 0.62%. Its return on equity (ROE) was not disclosed. The next earnings release is scheduled for April 30, 2026.
Earnings drift grade
Outlook vs expectations on the last report — not price action.
-
Forward outlook
2 target raises vs 2 cuts.
-
EPS & revenue
EPS beat estimates by 12.6%. Revenue missed estimates by 2.2%.
-
Profit surprise
EBITDA missed by 27 percent. Operating income missed by 46 percent.
-
Pre-earnings setup
Bar was high, analysts already very bullish.
-
Analyst signal
2 target raises, 2 target cuts.
-
Earnings quality
Positive free cash flow.
Earnings Call Summary
Cardinal Health reported first quarter revenue of $60.9 billion, up 22 percent year over year, with earnings per share of $3.17 beating consensus of $2.80. The company saw broad strength across all five business segments, particularly in pharmaceutical specialty solutions where profit grew 26 percent and specialty drug sales benefited from GLP-1 demand growth. The strong quarter reflected execution on strategy, successful integration of acquisitions, and robust underlying pharmaceutical utilization trends across the market.
Guidance Cardinal Health raised its full year earnings guidance to between $9.65 and $9.85 per share, up 35 cents from prior guidance. The company expects Pharma profit to grow 16 to 19 percent for the year, driven by strong drug demand and the Solaris Health acquisition closing soon. Free cash flow is now guided to $3 billion to $3.5 billion for the full year, up from prior range.
Clearly negative report. The company missed important expectations and likely triggers downward revisions.
Dividend
Cardinal Health offers an annual dividend rate of $2.05, yielding 0.93%. The dividend payout ratio is 31.19%, indicating a sustainable payout relative to earnings.
Insider Buying and Selling at Cardinal Health, Inc.
Recent insider activity at Cardinal Health includes Patricia Hemingway Hall purchasing 381 shares at an average price of $207.83 on April 15, 2026. On the selling side, Chief Information Officer Michelle Greene sold 2,746 shares at $228.47 on February 27, 2026, and Chief Financial Officer Aaron Alt sold a total of 6,570 shares in multiple transactions in February 2026, with prices ranging from $220.79 to $225.50.
Analysts Set New Price Targets
Analyst sentiment remains positive for Cardinal Health. On May 4, 2026, JP Morgan maintained a 'hold' rating with a $215 price target. Citigroup, TD Cowen, and Wells Fargo all maintained 'buy' ratings with price targets of $245, $255, and $245 respectively on May 1, 2026. The consensus among analysts is a 'strong buy', with an average target price of $245.27 based on 15 opinions.
About Cardinal Health
Cardinal Health, Inc. provides healthcare services and products in the U.S. and internationally. It operates through Pharmaceutical and Specialty Solutions, and Global Medical Products and Distribution segments. The company offers solutions for hospitals, healthcare systems, pharmacies, and more, distributing a wide range of pharmaceutical and medical products. Headquartered in Dublin, Ohio, Cardinal Health is led by CEO Jason M. Hollar and employs over 53,000 people.
Bottom Line
Lido Advisors' decision to cut its stake in Cardinal Health by nearly 25% is a notable move in the healthcare sector. Investors often track such changes in institutional holdings for insights into market sentiment. It's important to remember that 13F filings are backward-looking and may not reflect current positions.
Get Cardinal Health, Inc. alerts
New 13F filings, insider trades, and analyst moves on $CAH, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.